These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12351443)

  • 21. Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.
    Kacerovsky M; Brehm A; Chmelik M; Schmid AI; Szendroedi J; Kacerovsky-Bielesz G; Nowotny P; Lettner A; Wolzt M; Jones JG; Roden M
    J Intern Med; 2011 Feb; 269(2):189-99. PubMed ID: 21205021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats.
    Kuhlmann J; Neumann-Haefelin C; Belz U; Kalisch J; Juretschke HP; Stein M; Kleinschmidt E; Kramer W; Herling AW
    Diabetes; 2003 Jan; 52(1):138-44. PubMed ID: 12502504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes.
    Kautzky-Willer A; Krssak M; Winzer C; Pacini G; Tura A; Farhan S; Wagner O; Brabant G; Horn R; Stingl H; Schneider B; Waldhäusl W; Roden M
    Diabetes; 2003 Feb; 52(2):244-51. PubMed ID: 12540593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance.
    Korach-André M; Gao J; Gounarides JS; Deacon R; Islam A; Laurent D
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E106-16. PubMed ID: 15328072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity.
    Sinha R; Dufour S; Petersen KF; LeBon V; Enoksson S; Ma YZ; Savoye M; Rothman DL; Shulman GI; Caprio S
    Diabetes; 2002 Apr; 51(4):1022-7. PubMed ID: 11916921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.
    Krssak M; Falk Petersen K; Dresner A; DiPietro L; Vogel SM; Rothman DL; Roden M; Shulman GI
    Diabetologia; 1999 Jan; 42(1):113-6. PubMed ID: 10027589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between expression of FABPpm in skeletal muscle and insulin sensitivity in intramyocellular lipid-accumulated nonobese men.
    Kawaguchi M; Tamura Y; Kakehi S; Takeno K; Sakurai Y; Watanabe T; Funayama T; Sato F; Ikeda S; Ogura Y; Saga N; Naito H; Fujitani Y; Kanazawa A; Kawamori R; Watada H
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3343-52. PubMed ID: 24937540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
    Bajaj M; Suraamornkul S; Hardies LJ; Pratipanawatr T; DeFronzo RA
    Int J Obes Relat Metab Disord; 2004 Jun; 28(6):783-9. PubMed ID: 15024400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.
    Schrauwen-Hinderling VB; Mensink M; Hesselink MK; Sels JP; Kooi ME; Schrauwen P
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2917-21. PubMed ID: 18460571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In-vivo 1H-MR spectroscopy: the determination of the intra- and extramyocellular lipid content depending on the insulin effect in the direct offspring of type-2 diabetics].
    Brechtel K; Machann J; Jacob S; Strempfer A; Schick F; Häring HU; Claussen CD
    Rofo; 1999 Aug; 171(2):113-20. PubMed ID: 10506884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic Fat Deposition on Insulin Sensitivity: Correlation of Hepatocellular Lipid Content and
    Hong BS; Li Y; Lai S; Liu J; Guan H; Ke W; He X; Li Y
    J Diabetes Res; 2016; 2016():3684831. PubMed ID: 27882331
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.
    Petersen KF; Dufour S; Befroy D; Lehrke M; Hendler RE; Shulman GI
    Diabetes; 2005 Mar; 54(3):603-8. PubMed ID: 15734833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients.
    Szendroedi J; Anderwald C; Krssak M; Bayerle-Eder M; Esterbauer H; Pfeiler G; Brehm A; Nowotny P; Hofer A; Waldhäusl W; Roden M
    Diabetes Care; 2009 Feb; 32(2):209-14. PubMed ID: 18957532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus.
    van de Weijer T; Sparks LM; Phielix E; Meex RC; van Herpen NA; Hesselink MK; Schrauwen P; Schrauwen-Hinderling VB
    PLoS One; 2013; 8(2):e51648. PubMed ID: 23418416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.
    Cusi K; DeFronzo R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3077-84. PubMed ID: 10999789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
    Ryysy L; Häkkinen AM; Goto T; Vehkavaara S; Westerbacka J; Halavaara J; Yki-Järvinen H
    Diabetes; 2000 May; 49(5):749-58. PubMed ID: 10905483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity.
    Thamer C; Machann J; Bachmann O; Haap M; Dahl D; Wietek B; Tschritter O; Niess A; Brechtel K; Fritsche A; Claussen C; Jacob S; Schick F; Häring HU; Stumvoll M
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1785-91. PubMed ID: 12679474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance spectroscopy shows an inverse correlation between intramyocellular lipid content in human calf muscle and local glycogen synthesis rate.
    van der Graaf M; Tack CJ; de Haan JH; Klomp DW; Heerschap A
    NMR Biomed; 2010 Feb; 23(2):133-41. PubMed ID: 19739109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy.
    Simha V; Szczepaniak LS; Wagner AJ; DePaoli AM; Garg A
    Diabetes Care; 2003 Jan; 26(1):30-5. PubMed ID: 12502655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.
    Lattuada G; Costantino F; Caumo A; Scifo P; Ragogna F; De Cobelli F; Del Maschio A; Luzi L; Perseghin G
    Diabetologia; 2005 Apr; 48(4):741-7. PubMed ID: 15759111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.